Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB)
Clinical trial NCT06823401 · RECRUITING
Trial details
- NCT number
- NCT06823401
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-20
- Primary completion
- 2027-09-10
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.